Hepatitis c and Ejection fraction decreased

Summary:

Ejection fraction decreased is found among people with Hepatitis c, especially for people who are 60+ old.

The study analyzes which people have Ejection fraction decreased with Hepatitis c. It is created by eHealthMe based on reports of 29 people who have Hepatitis c from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

What is Ejection fraction decreased?

Ejection fraction decreased (systolic heart failure) is found to be associated with 1,063 drugs and 1,253 conditions by eHealthMe. Check the latest studies of Ejection fraction decreased.



On Jul, 19, 2026

29 people who have Hepatitis C and Ejection Fraction Decreased are studied.

Would you have Ejection fraction decreased when you have Hepatitis c?

Age of people who have Hepatitis C and experienced Ejection Fraction Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.85 %
  • 40-49: 30.77 %
  • 50-59: 26.92 %
  • 60+: 38.46 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 4 people, 13.79%
  2. Type 2 Diabetes: 3 people, 10.34%
  3. High Blood Cholesterol: 3 people, 10.34%
  4. Allergic Rhinitis: 3 people, 10.34%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 6.90%
  6. Headache (pain in head): 2 people, 6.90%
  7. Dyslipidaemia (abnormal amount of lipids): 2 people, 6.90%
  8. Constipation: 2 people, 6.90%
  9. Stress And Anxiety: 1 person, 3.45%
  10. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 3.45%

Common drugs taken by these people *:

  1. Ribavirin: 8 people, 27.59%
  2. Peg-Intron: 7 people, 24.14%
  3. Rebetol: 7 people, 24.14%
  4. Glucophage: 3 people, 10.34%
  5. Nasonex: 3 people, 10.34%
  6. Sovaldi: 3 people, 10.34%
  7. Xanax: 2 people, 6.90%
  8. Paracetamol: 2 people, 6.90%
  9. Amlodipine: 2 people, 6.90%
  10. Pegasys: 2 people, 6.90%

Common symptoms for these people *:

  1. Dyspnea (difficult or laboured breathing): 10 people, 34.48%
  2. Pleural Effusion (water on the lungs): 6 people, 20.69%
  3. Cardiac Failure Congestive: 6 people, 20.69%
  4. Cardiomyopathy (weakening of the heart muscle): 5 people, 17.24%
  5. Acute Kidney Failure: 4 people, 13.79%
  6. Cardiac Failure: 4 people, 13.79%
  7. Tricuspid Valve Incompetence (inefficient heart valve): 4 people, 13.79%
  8. Aortic Valve Incompetence: 4 people, 13.79%
  9. Malaise (a feeling of general discomfort or uneasiness): 4 people, 13.79%
  10. Fatigue (feeling of tiredness): 4 people, 13.79%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ejection fraction decreased?

- Check whether Ejection fraction decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ejection fraction decreased:

All the conditions that are associated with Ejection fraction decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ejection fraction decreased and Hepatitis c, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: